GABA-A receptor subtypes in the brain: A paradigm for CNS drug discovery?

Drug Discovery Today

Volumn 8, Issue 10, 2003, Pages 445-450

  Whiting, Paul J ^a  

^a NEUROSCIENCE RESEARCH CENTRE   (United Kingdom)

Author keywords

Anaesthetic; Anxiety; Benzodiazepine; Cognition; Compound; Drug Discovery; GABA; Neurobiology; Pharmaceutical Science; Pharmacology; Receptor; Transgenic

Indexed keywords

4 AMINOBUTYRIC ACID A RECEPTOR; ANESTHETIC AGENT; BARBITURIC ACID DERIVATIVE; BENZODIAZEPINE DERIVATIVE; DIAZEPAM; ETOMIDATE; HALOTHANE; PROPOFOL; RECEPTOR SUBTYPE;

CENTRAL NERVOUS SYSTEM; DRUG MECHANISM; DRUG RECEPTOR BINDING; DRUG TARGETING; GENE FUNCTION; NONHUMAN; REVIEW;

ANIMALS; BRAIN; CENTRAL NERVOUS SYSTEM; DRUG DELIVERY SYSTEMS; HUMANS; RECEPTORS, GABA-A; TECHNOLOGY, PHARMACEUTICAL;

EID: 0038178996     PISSN: 13596446     EISSN: None     Source Type: Journal    
DOI: 10.1016/S1359-6446(03)02703-X     Document Type: Review

References (42)

1. Whiting P.J., et al. GABA. Creighton T.E. Encyclopedia of Molecular Biology. 1999;1957-1959 Wiley Interscience.
2. Kemp J.A., McKernan R.M. NMDA receptors as drug targets. Nat. Neurosci. 5:(Suppl. 1):2002;1039-1042.
3. Meldrum B., Whiting P.J. Anticonvulsants acting on the GABA system. Mohler H. Handbook of Experimental Pharmacology: Inhibitory Amino Acid Transmitters. 2001;173-194 Springer-Verlag. (Chapter 6).
4. No author (2002) Neuropsychopharmacology (edn 5) (Davis, K.L. et al., eds), Lippincott, Williams and Wilkins.
5. Stewart S.H., Westra H.A. Benzodiazepine side-effects: from the bench to the clinic. Curr. Pharm. Des. 8:2002;1-3.
6. Squires R.F., et al. Some properties of brain specific benzodiazepine receptors: new evidence for multiple receptors. Pharmacol. Biochem. Behav. 10:1979;825-830.
7. Whiting P.J., et al. Pharmacological subtypes of GABA-A receptors based upon subunit composition. Martin D.L., Olsen R.W. GABA in the Nervous System: A View at Fifty Years. 2001;113-126 Williams and Wilkins, Lippincott.
8. Sieghart W., Sperk G. Subunit composition, distribution and function of GABA-A receptor subtypes. Curr. Top. Med. Chem. 2:2002;795-816.
9. Barnard E.A., et al. International Union of Pharmacololgy. XV. Subtypes of gamma-aminobutyric acid A receptors: classification on the basis of subunit structure and receptor function. Pharmacol. Rev. 50:1998;291-313.
10. Mohler H., et al. The benzodiazepine site of GABA-A receptors. Martin D.L., Olsen R.W. GABA in the Nervous System: A View at Fifty Years. 2001;97-112 Williams and Wilkins, Lippincott.
11. Luddens H., et al. Cerebellar GABA-A receptor selective for a behavioural alcohol antagonist. Nature. 346:1990;648-651.
12. Wieland H.A., et al. A single histidine in GABA-A receptors is essential for benzodiazepine agonist binding. J. Biol. Chem. 267:1992;1426-1429.
13. Wells T., Carter D.A. Genetic engineering of neural function in transgenic rodents: towards a comprehensive strategy. J. Neurosci. Methods. 108:2001;111-130.
14. Rudolph U., et al. Benzodiazepine actions mediated by specific gamma-aminobutyric acid(A) receptor subtypes. Nature. 401:1999;796-800.
15. McKernan R.M., et al. Sedative but not anxiolytic properties of benzodiazepines are mediated by the GABA(A) receptor alpha1 subtype. Nat. Neurosci. 3:2000;587-592.
16. Low K., et al. Molecular and neuronal substrate for the selective attenuation of anxiety. Science. 290:2000;131-134.
17. Crestani F., et al. Mechanism of action of the hypnotic zolpidem in vivo. Br. J. Pharmacol. 131:2000;1251-1254.
18. Pirker S., et al. GABA(A) receptors: immunocytochemical distribution of 13 subunits in the adult rat brain. Neuroscience. 101:2000;815-850.
19. Fritschy J.M., Mohler H. GABA-A-receptor heterogeneity in the adult rat brain: differential regional and cellular distribution of seven major subunits. J. Comp. Neurol. 359:1995;154-194.
20. Loup F., et al. A highly sensitive immunofluorescence procedure for analysing the subcellular distribution of GABA-A receptor subunits in the human brain. J. Histochem. Cytochem. 46:1998;1129-1139.
21. McNair D.M., et al. Simulated public speaking as a model of clinical anxiety. Psychopharmacology (Berl.). 77:1982;7-10.
22. Goetz R.R., et al. Acute panic inventory symptoms during CO(2) inhalation and room-air hyperventilation among panic disorder patients and normal controls. Depress. Anxiety. 14:2001;123-136.
23. Riba J., et al. Differential effects of alprazolam on the baseline and fear-potentiated startle reflex in humans: a dose-response study. Psychopharmacology (Berl.). 157:2001;358-367.
24. Wisden W., et al. The distribution of 13 GABA-A receptor subunit mRNAs in the rat brain. I. Telencephalon, diencephalon, mesencephalon. J. Neurosci. 12:1992;1040-1062.
25. Sur C., et al. Autoradiographic localisation of alpha5 subunit-containing GABA-A receptors in rat brain. Brain Res. 822:1999;265-270.
26. Burgess N., et al. The human hippocampus and spatial and episodic memory. Neuron. 35:2002;625-641.
27. Collinson N., et al. Enhanced learning and memory and altered GABAergic synaptic transmission in mice lacking the alpha 5 subunit of the GABA-A receptor. J. Neurosci. 22:2002;5572-5580.
28. Crestani F., et al. Trace fear conditioning involves hippocampal alpha5 GABA(A) receptors. Proc. Natl. Acad. Sci. U. S. A. 99:2002;8980-8985.
29. Chapouthier G., Venault P. GABA-A receptor complex and memory processes. Curr. Top. Med. Chem. 2:2002;841-851.
30. Wafford K.A., et al. Differences in affinity and efficacy of benzodiazepine receptor ligands at recombinant gamma-aminobutyric acidA receptor subtypes. Mol. Pharmacol. 43:1993;240-244.
31. McNamara R.K., Skelton R.W. The neuropharmacological and neurochemical basis of place learning in the Morris water maze. Brain Res. Rev. 18:1993;33-49.
32. Harrison N.L., et al. Alcohol and general anaesthetic actions on the GABA-A receptor. Martin D.L., Olsen R.W. GABA in the Nervous System: A View at Fifty Years. 2001;167-190 Williams and Wilkins, Lippincott.
33. Belelli D., et al. The interaction of the general anaesthetic etomidate with the gamma-aminobutyric acid type A receptor is influenced by a single amino acid. Proc. Natl. Acad. Sci. U. S. A. 94:1997;11031-11036.
34. Jurd R., et al. General anaesthetic actions in vivo strongly attenuated by a point mutation in the GABA(A) receptor beta3 subunit. FASEB J. 17:2003;250-252.
35. Sur C., et al. Preferential coassembly of alpha4 and delta subunits of the gamma-aminobutyric acidA receptor in rat thalamus. Mol. Pharmacol. 56:1999;110-115.
36. Quirk K., et al. Model of subunit composition of gamma-aminobutyric acid A receptor subtypes expressed in rat cerebellum with respect to their alpha and gamma/delta subunits. J. Biol. Chem. 269:1994;16020-16028.
37. Mody I. Distinguishing between GABA(A) receptors responsible for tonic and phasic conductances. Neurochem. Res. 26:2001;907-913.
38. Nusser Z., Mody I. Selective modulation of tonic and phasic inhibitions in dentate gyrus granule cells. J. Neurophysiol. 87:2002;2624-2628.
39. Nusser Z., et al. Segregation of different GABA-A receptors to synaptic and extrasynaptic membranes of cerebellar granule cells. J. Neurosci. 18:1998;1693-1703.
40. Haas K.F., Macdonald R.L. GABAA receptor subunit gamma2 and delta subtypes confer unique kinetic properties on recombinant GABAA receptor currents in mouse fibroblasts. J. Physiol. 514:1999;27-45.
41. Brown N., et al. Pharmacological characterization of a novel cell line expressing human alpha(4)beta(3)delta GABA(A) receptors. Br. J. Pharmacol. 136:2002;965-974.
42. Spigelman I., et al. Behaviour and physiology of mice lacking the GABA-A-receptor delta subunit. Epilepsia. 43:2002;3-8.